CA1097220A - Controlled release tablet - Google Patents

Controlled release tablet

Info

Publication number
CA1097220A
CA1097220A CA262,583A CA262583A CA1097220A CA 1097220 A CA1097220 A CA 1097220A CA 262583 A CA262583 A CA 262583A CA 1097220 A CA1097220 A CA 1097220A
Authority
CA
Canada
Prior art keywords
tablet
cellulose
medicament
polymer
hydrophilic polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA262,583A
Other languages
English (en)
French (fr)
Inventor
Aaron L. Weiss
Richard W. Walton
Albert E. De Lorimier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of CA1097220A publication Critical patent/CA1097220A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
CA262,583A 1975-10-10 1976-10-04 Controlled release tablet Expired CA1097220A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62131675A 1975-10-10 1975-10-10
US621,316 1975-10-10

Publications (1)

Publication Number Publication Date
CA1097220A true CA1097220A (en) 1981-03-10

Family

ID=24489671

Family Applications (1)

Application Number Title Priority Date Filing Date
CA262,583A Expired CA1097220A (en) 1975-10-10 1976-10-04 Controlled release tablet

Country Status (16)

Country Link
JP (1) JPS5264420A (nl)
AU (1) AU516051B2 (nl)
BE (1) BE847095A (nl)
CA (1) CA1097220A (nl)
CH (1) CH616843A5 (nl)
DE (1) DE2645547A1 (nl)
DK (1) DK454876A (nl)
FR (1) FR2326933A1 (nl)
GB (1) GB1568837A (nl)
HU (1) HU175540B (nl)
IE (1) IE44540B1 (nl)
NL (1) NL7611148A (nl)
NO (1) NO763450L (nl)
PH (1) PH14564A (nl)
SE (1) SE435569B (nl)
ZA (1) ZA765931B (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
JPS5626810A (en) * 1979-08-06 1981-03-16 Kurishiyuna Mitora Arun Antiacid delivering form controlled and treating method using said form
FR2494112B1 (nl) * 1980-11-19 1986-01-10 Laruelle Claude
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
HU190619B (en) 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
DE3448522C2 (de) * 1983-11-11 1995-08-24 Egyt Gyogyszervegyeszeti Gyar Pharmazeutische Präparate, insbesondere Tabletten, mit geregelter beziehungsweise verzögerter Wirkstoffabgabe, sowie Verfahren zur Herstellung derselben
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
DE3420666A1 (de) 1984-06-02 1985-12-05 Mannesmann Rexroth GmbH, 8770 Lohr Niveauregeleinrichtung fuer fahrzeuge mit mindestens einem hydraulischen schwingungsdaempfer
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
JPH0667828B2 (ja) * 1985-10-09 1994-08-31 日研化学株式会社 バルプロ酸ナトリウムの持続性顆粒製剤
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
GB8913889D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
IL119627A (en) 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet

Also Published As

Publication number Publication date
FR2326933A1 (fr) 1977-05-06
JPS5264420A (en) 1977-05-27
FR2326933B1 (nl) 1979-03-02
AU1844676A (en) 1978-04-13
SE7611241L (sv) 1977-04-11
HU175540B (hu) 1980-08-28
AU516051B2 (en) 1981-05-14
IE44540L (en) 1977-04-10
SE435569B (sv) 1984-10-08
DE2645547A1 (de) 1977-04-14
ZA765931B (en) 1977-09-28
NO763450L (nl) 1977-04-13
GB1568837A (en) 1980-06-04
IE44540B1 (en) 1981-12-30
NL7611148A (nl) 1977-04-13
BE847095A (fr) 1977-01-31
PH14564A (en) 1981-09-24
CH616843A5 (en) 1980-04-30
DK454876A (da) 1977-04-11

Similar Documents

Publication Publication Date Title
US4252786A (en) Controlled release tablet
CA1097220A (en) Controlled release tablet
US4610870A (en) Controlled release formulation
US4756911A (en) Controlled release formulation
Gazzaniga et al. Oral delayed-release system for colonic specific delivery
US4666705A (en) Controlled release formulation
DE68907762T3 (de) Arzneizubereitung mit gesteuerter Wirkstofffreisetzung und Verfahren zu deren Herstellung.
EP1101489B1 (en) Sustained release heterodisperse hydrogel systems for insoluble drugs
CA2206233C (en) Combination dosage form comprising cetirizine and pseudoephedrine
KR100205276B1 (ko) 서방성 정제
US4433076A (en) Coating agent for medicaments and methods for making and using the same
AU2002248792B2 (en) A novel coating for a sustained release pharmaceutical composition
AU750617B2 (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
EP0250374B1 (en) Therapeutic system for controlled release of drugs
GB2181052A (en) Pharmaceutical composition
US6558700B1 (en) Multiple-unit sustained release tablets
CA2555295C (en) Extended release coated mini-tablets of venlafaxine hydrochloride
US20030099710A1 (en) Granule modulating hydrogel system
US4851233A (en) Sustained release formulations
US5635208A (en) Granulation process for producing an acetaminophen and diphenhydramine hydrochloride composition and composition produced by same
JP2003508420A (ja) 経口投与に適した、制御された放出の経口用量
AU2004299077A1 (en) Sustained release torsemide dosage forms
US20060105035A1 (en) Sustained release heterodisperse hydrogel systems for insoluble drugs
WO2005009407A2 (en) Oral pharmaceutical formulations of olanzapine
WO1990006107A1 (en) Sustained release diltiazem formulation

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 19980310